Imperial College London

Dr Hannah M Cheeseman

Faculty of MedicineDepartment of Infectious Disease

Postdoctoral Researcher & Clinical Trials Laboratory Manager



+44 (0)20 7594 2540hannah.cheeseman




452 - Shattock GroupNorfolk PlaceSt Mary's Campus






Martin GM, Russell RA, Mundsperger P, et al., 2023, Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens., Npj Vaccines, Vol:8, ISSN:2059-0105

Szubert AJ, Pollock KM, Cheeseman HM, et al., 2023, COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2., Eclinicalmedicine, Vol:56, ISSN:2589-5370, Pages:1-13

Day S, Kaur C, Cheeseman H, et al., 2022, Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens, Frontiers in Immunology, Vol:13, ISSN:1664-3224, Pages:1-17

Elliott T, Cheeseman HM, Evans AB, et al., 2022, Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines, Plos Pathogens, Vol:18, ISSN:1553-7366, Pages:1-20


Day S, de Groot E, Cheeseman H, et al., 2022, Towards a prophylactic HIV vaccine: fine needle aspiration reveals cellular features of human lymph nodes compared with blood in the EAVI2020_01 study, WILEY, Pages:39-40, ISSN:1464-2662

More Publications